• Mashup Score: 2

    Product launch and expansionThe company plans a soft launch of My Day multifocal contact lens this summer. The lens will feature a new multifocal design, including a +3.00 D add. Warner says the lens is offering an 80% success rate with first fits and 90% with second fits.“Technology in multifocals is one of the things that if it excited doctors, it excites patients,” says Warner. “This is an…

    Tweet Tweets with this article
    • CHECK IT OUT: In @OptometryTimes' top story of the week, @CooperVision's executive VP Jerry Warner speaks about the company’s recent product expansions and place in the #contactlens market. #optometry #ophthalmoloy https://t.co/fBFo0zTf2S

  • Mashup Score: 2

    ATLANTA — Alcon presented the latest innovations to the company’s products at this year’s SECO meeting, including Precision1 for Astigmatism, a multi-dose format of Systane Hydration PF and news of an upcoming monthly reusable contact lens. “Everyone knows that the past year has been very challenging for the industry as well as the optometric profession,” Rick

    Tweet Tweets with this article
    • Alcon presented the latest innovations to the company’s products at this year’s #SECO2021 meeting, including Precision1 for #Astigmatism, a multi-dose format of Systane Hydration PF and news of an upcoming monthly reusable #contactlens. https://t.co/C6Dh0npo1L

  • Mashup Score: 2

    Johnson & Johnson Vision announced the launch of Acuvue Oasys Multifocal with Pupil Optimized Design for patients with presbyopia. The company said in a press release that the new lens is embedded with a proprietary wetting agent and has a pupil optimized design and hybrid back curve technology, allowing patients with presbyopia to see objects at all distances.

    Tweet Tweets with this article
    • #Optometry and #EyeCare news: Johnson & Johnson Vision announced the launch of Acuvue Oasys Multifocal #contactlens with Pupil Optimized Design for patients with #presbyopia. https://t.co/jmL8OBbNxS

  • Mashup Score: 0

    MediPrint Ophthalmic announced that the SIGHT-1 clinical trial found a favorable safety and tolerability profile and demonstrated single dose efficacy of the LLT-BMT1 drug-eluting contact lens to treat mild to moderate glaucoma or ocular hypertension. “I was excited to study this investigational treatment and believe that LLT-BMT1’s unique product presentation and potential benefits

    Tweet Tweets with this article
    • MediPrint Ophthalmic announced that the SIGHT-1 clinical trial found a favorable safety and tolerability profile and demonstrated single dose efficacy of the LLT-BMT1 drug-eluting #contactlens to treat mild to moderate #glaucoma or ocular hypertension. https://t.co/DgjQnEB6fI

  • Mashup Score: 1

    AZR-MD-001, under investigation for the treatment of contact lens discomfort, has reached the primary endpoints in the phase 2 ECLIPTIC study, according to a press release from Azura Ophthalmics. Topline results from the single-center, single-masked, vehicle-controlled, randomized, parallel-group study showed 26 participants treated with twice-weekly AZR-MD-001 (selenium disulfide), applied to

    Tweet Tweets with this article
    • Phase 2 trial of treatment for contact lens discomfort reaches primary endpoints #ContactLens https://t.co/OPAbAeKqai

  • Mashup Score: 0

    Bausch Health announced in a press release that one of its affiliates entered an exclusive licensing agreement for a myopia control contact lens developed by Australian nonprofit Brien Holden Vision Institute. “For decades, BHVI [Brien Holden Vision Institute] has sought solutions to fulfill the unmet needs in the ophthalmic space by innovating commercially relevant technologies, including those

    Tweet Tweets with this article
    • Bausch Health announced in a press release that one of its affiliates entered an exclusive licensing agreement for a #myopiacontrol #contactlens developed by Australian nonprofit Brien Holden Vision Institute. https://t.co/Jr9cBnd0Uh

  • Mashup Score: 1

    The CDC disseminated information about hygienic contact lens practices through social media, newsletters and other digital channels as part of Contact Lens Health Week from Aug. 17 to 21. The events were primarily digital due to COVID-19, Sarah Collier, MPH, analytic epidemiologist, Division of Foodborne, Waterborne and Environmental Diseases, National Center for Emerging Zoonotic Infectious

    Tweet Tweets with this article
    • The CDC disseminated information about hygienic #contactlens practices during the #COVID19 #pandemic through social media, newsletters and other digital channels as part of Contact Lens Health Week from Aug. 17 to 21. https://t.co/FkYhx9vWed

  • Mashup Score: 0

    Topcon Healthcare introduced into the U.S. market the Aladdin-M, which measures corneal curvature, pupil dynamics and axial length metrics and incorporates features for keratoconus screening and contact lens fitting. Its software can document axial length measurements and track prescription changes over time, the company said in a press release.

    Tweet Tweets with this article
    • Topcon Healthcare introduced the Aladdin-M, which measures corneal curvature, pupil dynamics and axial length metrics and incorporates features for #keratoconus screening and #contactlens fitting. https://t.co/AlT4ZMyoSB